Make an Appointment

frontdesk@spineandsportsrehabny.com    Call Us: (631) 203-4300

regenerative medicine

Regenerative Medicine: What It Is, How It Works, and Who It May Help

TL;DR

Regenerative medicine uses biologic treatments, such as platelet-rich plasma (PRP), bone marrow concentrate, and prolotherapy, to support the body's own healing processes in damaged joints, tendons, ligaments, and spinal structures. It differs from conventional care by targeting the tissue environment rather than only managing symptoms. Appropriateness varies by patient, condition, and severity, and requires a thorough clinical evaluation.

If you’re comparing treatments, start with the clinic’s overview of regenerative medicine options before discussing your options with a clinician.

Key takeaways

  • Regenerative medicine uses biologic substances to support tissue repair rather than simply masking pain or removing tissue surgically.
  • PRP therapy has the most published clinical support among regenerative options, particularly for knee osteoarthritis and tendinopathy.
  • Biologic treatments work best as part of a broader plan that includes rehabilitation and mechanical correction, not as standalone injections.
  • Candidacy for regenerative medicine depends on a specific diagnosis, the tissue involved, and the patient's full clinical picture.
  • Any regenerative treatment should be administered by a licensed, credentialed physician following a thorough evaluation, not based on a self-assessment.

What Is Regenerative Medicine and How Does It Differ from Conventional Care

Regenerative medicine uses biologic substances, often derived from your own body, to support the body's natural repair processes in damaged or degenerated tissue. Unlike conventional treatments that mainly reduce symptoms, regenerative approaches aim to address the tissue itself, though results vary by patient and condition.

Conventional musculoskeletal care typically focuses on managing pain through anti-inflammatory medications, cortisone injections, or surgery. Each of those tools has its place, but they do not all address the underlying tissue condition. Regenerative medicine takes a different starting point: rather than suppressing a symptom or removing a structure, it introduces biologic material, such as concentrated growth factors from your own blood or cellular components from other sources, to support the environment in which healing can occur.

Dr. Jordan Sudberg, MD, a physiatrist and pain management specialist at Spine & Sports Rehab NY on Long Island, puts it plainly: "Regenerative medicine is an area of treatment focused on using biologic approaches to support the body's natural healing processes. The right approach depends on the patient's condition, medical history, goals, and the source of their pain." That last phrase matters: regenerative treatments are not chosen from a menu. They follow a careful evaluation of what is actually causing the problem.

For patients who have been through rounds of physical therapy, oral medications, or standard injections without lasting relief, regenerative options are often worth a conversation. Whether they are appropriate depends entirely on the individual. You can learn more about the full range of options at the <a href="https://spineandsportsrehabny.com/our-services/regenerative-medicine/">regenerative medicine services page</a> for Spine & Sports Rehab NY.

Common Conditions That Regenerative Approaches May Address

Regenerative treatments are most commonly explored for musculoskeletal conditions including knee osteoarthritis, rotator cuff injuries, tendinopathy, ligament sprains, and certain spine and disc problems. Candidacy depends on the severity of the condition, the specific tissue involved, and the patient's overall health.

Most people who ask about regenerative medicine are dealing with one of a fairly predictable set of conditions: persistent joint pain that has not resolved with conservative care, a partial tendon or ligament injury that keeps flaring, or degenerative changes in the spine or a major joint that make surgery feel premature or undesirable.

Knee osteoarthritis is among the most studied applications, with platelet-rich plasma (PRP) therapy receiving the most clinical attention. Regenerative treatment for knee osteoarthritis is a dedicated topic worth exploring in depth if that is your primary concern. Rotator cuff injuries, which are common among athletes and active adults alike, have also been the subject of growing research into biologic support for partial tears and chronic tendon pain. Similarly, regenerative medicine for tendinopathy and overuse injuries covers conditions like tennis elbow, Achilles tendinopathy, and patellar tendinopathy that respond poorly to rest alone.

For the spine, regenerative injections for disc and spine pain represent a developing area: conditions such as degenerative disc disease and facet joint degeneration are being studied for potential biologic support, though the evidence base is still maturing compared to peripheral joint applications.

Athletes, from competitive players to weekend golfers and pickleball enthusiasts, are a growing share of patients exploring these options. Regenerative medicine for sports injuries in athletes is a topic that warrants its own discussion, particularly for those trying to return to activity without surgery.

The Main Types of Regenerative Treatments Used in Musculoskeletal Care

The most common regenerative treatments in musculoskeletal care are platelet-rich plasma (PRP) therapy, stem cell or bone marrow concentrate injections, and prolotherapy. Each works through a different biologic mechanism and is suited to different conditions and tissue types.

Platelet-rich plasma therapy, often called PRP, involves drawing a small sample of the patient's own blood, processing it in a centrifuge to concentrate the platelets and the growth factors they carry, and injecting that concentrate into the area of concern. A dedicated article on how platelet-rich plasma therapy works covers the process in full, but the short version is that platelets release proteins that signal the body's repair cells to become more active.

Stem cell therapy for joints and the spine typically uses bone marrow aspirate concentrate or, in some protocols, adipose-derived cellular material. The goal is to introduce cells and signaling factors that may support tissue repair, though the science around exactly how and when this works is still being clarified through ongoing research.

Prolotherapy is an older approach involving the injection of a mild irritant solution, most often dextrose, into a ligament or tendon attachment site to stimulate a localized healing response. Prolotherapy for ligament and tendon pain is particularly relevant for chronic sprains and hypermobility-related pain that has not responded to other conservative care.

One factor that improves the accuracy and safety of all three approaches is ultrasound guidance. How ultrasound guidance improves regenerative injections is worth understanding: real-time imaging allows the clinician to confirm needle placement in the target tissue rather than relying on surface anatomy alone, which is especially important for small or deep structures.

What to Expect During a Regenerative Medicine Evaluation

A regenerative medicine evaluation begins with a thorough history and physical examination, often followed by imaging review or diagnostic ultrasound, to determine the actual source of pain. The clinician then discusses whether a biologic treatment is appropriate and, if so, which type fits the patient's specific condition and goals.

Many patients arrive having already accumulated MRI reports, X-rays, and notes from previous providers. A good evaluation does not discard that history but builds on it. The first priority is confirming the pain generator, the specific tissue or structure that is actually causing the patient's symptoms, because treating the wrong structure with even the best biologic material will not produce meaningful improvement.

Diagnostic musculoskeletal ultrasound is frequently used alongside clinical examination to visualize tendons, ligaments, bursae, and joint spaces in real time. This is different from an MRI taken weeks earlier: it allows the clinician to see the tissue as it behaves under gentle stress and to correlate the image directly with where the patient reports pain.

After diagnosis, the conversation turns to options. A patient with mild-to-moderate knee osteoarthritis and no significant mechanical instability may be a reasonable candidate for a PRP protocol. A patient with a full-thickness rotator cuff tear may need a surgical opinion first. Understanding who is a good candidate for regenerative medicine is a nuanced question with no universal answer, which is why the evaluation step cannot be skipped.

What to expect after a regenerative injection is also part of this conversation: most biologic injections involve a short period of increased soreness, a planned reduction in activity, and a structured rehabilitation timeline before any assessment of benefit.

How Regenerative Care Fits Into a Broader Treatment Plan

Regenerative treatments are rarely used in isolation. They work best as part of a plan that also includes physical rehabilitation, activity modification, and, where appropriate, other non-surgical interventions. Biologic injections do not replace the work of restoring movement, strength, and mechanics.

Dr. Jordan Sudberg is direct on this point. Discussing the limits of biologic treatments alone, he has noted: "Regenerative medicine isn't a one-size-fits-all miracle fix; without correcting underlying mechanical imbalances and structural stressors first, biologic treatments won't achieve lasting tissue repair." For patients, this means that receiving a PRP injection and then returning to the same movement patterns or loading habits that contributed to the injury in the first place is unlikely to produce durable results.

A well-constructed plan might combine a regenerative injection to support tissue repair with a course of physical therapy to restore strength and mechanics, activity coaching to reduce load on the healing structure, and follow-up imaging or reassessment at a defined interval. Comparing regenerative medicine vs. cortisone injections is a common question in this planning conversation: cortisone can provide faster short-term relief but does not support tissue repair and carries risks with repeated use, while PRP aims at a different goal and has a different risk profile.

For patients with spine pain, regenerative injections may be combined with other conservative interventions depending on the clinical picture. The broader context is that physiatry, the medical specialty focused on function and rehabilitation, is well suited to this kind of integrated planning because it does not begin from a surgical or a purely pharmacological perspective.

What the Research Currently Says

The evidence for regenerative medicine in musculoskeletal care is growing but uneven. PRP for knee osteoarthritis and certain tendinopathies has the most published support. Stem cell therapies and prolotherapy have promising early data but require more large, well-controlled trials before definitive conclusions can be drawn.

PRP has been studied in a substantial number of randomized controlled trials, particularly for knee osteoarthritis and lateral epicondylitis (tennis elbow). A 2021 systematic review and meta-analysis published in peer-reviewed literature found that PRP outperformed hyaluronic acid for pain and function outcomes in knee osteoarthritis at six and twelve months, though study heterogeneity remains a limitation. The American Academy of Orthopaedic Surgeons has acknowledged PRP as an emerging option while noting that standardization of preparation protocols remains a challenge.

Stem cell therapies, specifically bone marrow aspirate concentrate, have shown early promise in smaller trials for knee cartilage defects and degenerative joint conditions, but larger randomized controlled trials are still needed. Regulatory status also varies: patients should be aware that many stem cell products marketed directly to consumers are not FDA-cleared for musculoskeletal use, which is one reason why receiving any biologic treatment through a licensed, credentialed physician is important.

Prolotherapy has a longer research history than its lower profile might suggest, with randomized trials supporting its use for chronic low back pain and ligament-related knee pain. The Cochrane Collaboration has published reviews examining the evidence, finding it supportive but variable across study designs.

None of this means regenerative medicine works for everyone or for every condition. As Dr. Sudberg has said: "Regenerative medicine should not be viewed as a one-size-fits-all solution. The important question is whether a particular regenerative treatment is appropriate for the individual patient and the specific tissue or condition being treated." That framing is the honest starting point for any patient considering these options.

Is Regenerative Medicine Right for You

Whether regenerative medicine is appropriate for you depends on your specific diagnosis, the tissue involved, the severity of the condition, your overall health, and what you have already tried. There is no substitute for a one-on-one evaluation with a clinician who can assess your individual situation.

If you have been managing persistent joint, tendon, spine, or sports-related pain and feel like you are stuck between continuing treatments that are not working and accepting a surgery you are not ready for, regenerative options may be worth exploring. They are not the right fit for every patient or every condition, and they are not a shortcut around rehabilitation. But for the right candidate, biologic treatments can be a meaningful part of moving toward less pain and better function.

Patients like Robert from Manhasset, New York, have shared that after treatment at Spine & Sports Rehab NY, "I can now go about my daily activities and work with less pain." That kind of outcome, being able to return to ordinary life with greater comfort, is a realistic goal for many patients, though individual results vary and no specific outcome can be promised.

James from New York, New York, reflected simply: "I can't put into words how immensely grateful I am for Dr. Sudberg's medical care." Patient experiences like these are individual, not typical, but they reflect the kind of care that a thorough, diagnosis-first evaluation is designed to deliver.

If you are curious whether you might be a candidate, the most useful next step is a consultation, not a search for the right injection. A clinician needs to understand your history, examine the tissue, and discuss your goals before any treatment recommendation is appropriate. Please consult a qualified clinician about your own situation before pursuing any treatment.

Frequently asked questions

What is regenerative medicine?

Regenerative medicine uses biologic treatments, such as platelet-rich plasma, bone marrow concentrate, and prolotherapy, to support the body's natural healing processes in damaged or degenerated musculoskeletal tissue. It differs from conventional care by targeting tissue repair rather than only symptom relief.

Who is a good candidate for regenerative medicine?

Good candidates are generally patients with confirmed musculoskeletal diagnoses, such as knee osteoarthritis, tendinopathy, or partial ligament injuries, who have not achieved lasting relief from conservative care and are not ready for or do not need surgery. Candidacy must be determined by a clinician after a full evaluation.

What conditions can regenerative medicine treat?

Regenerative treatments are most commonly used for knee osteoarthritis, rotator cuff injuries, tendinopathy, ligament sprains, and certain spine and disc conditions. The appropriateness of a specific treatment depends on the tissue involved and the severity of the condition.

Is regenerative medicine safe?

When administered by a licensed, credentialed physician following proper evaluation and using FDA-compliant protocols, regenerative treatments have a generally favorable safety profile. Risks vary by treatment type and patient. Patients should avoid unregulated stem cell clinics that market unapproved products directly to consumers.